Literature DB >> 29707647

Fluorescence-Based Assays for Measuring Doxorubicin in Biological Systems.

Melinda K Kauffman1, Megan E Kauffman2, Hong Zhu2, Zhenquan Jia3, Y Robert Li2,3,4,5.   

Abstract

Detection and measurement of doxorubicin in biological systems, including body fluids, cells, and tissues, are instrumental in understanding the mechanisms of action of this widely used drug in treating cancer as well as in causing adverse effects. In this article, we, for the first time, characterized the use of fluorescence-based techniques, including fluorescence spectrometry, microscopy, and flow cytometry in measuring and/or detecting doxorubicin in biological systems, including cell lysates and cultured intact cells. We showed that doxorubicin has a maximum excitation and emission wavelength of 470 and 560 nm, respectively. The detection sensitivity by fluorescence spectrometry is less than 0.1 μM in buffers and cell lysates. Fluorescence microscopy demonstrated the readily detection of concentration-dependent accumulation of doxorubicin in cultured cells via either green or red fluorescence, but with green fluorescence showing a higher sensitivity of detection. Flow cytometry also revealed sensitive detection of doxorubicin accumulation in cell suspensions in a concentration-dependent manner. The readily and sensitive measurement and detection of doxorubicin by the above three fluorescence-based techniques has important implications in studying the cellular dynamics of doxorubicin in both cancer and normal cells under various experimental conditions.

Entities:  

Keywords:  Doxorubicin; Flow cytometry; Fluorescence; Microscopy; Spectrometry

Year:  2016        PMID: 29707647      PMCID: PMC5921830          DOI: 10.20455/ros.2016.873

Source DB:  PubMed          Journal:  React Oxyg Species (Apex)


  4 in total

Review 1.  Doxorubicin-induced cardiomyopathy.

Authors:  P K Singal; N Iliskovic
Journal:  N Engl J Med       Date:  1998-09-24       Impact factor: 91.245

Review 2.  Cardiotoxicity of anticancer treatments: what the cardiologist needs to know.

Authors:  Michael S Ewer; Steven M Ewer
Journal:  Nat Rev Cardiol       Date:  2010-10       Impact factor: 32.419

3.  Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial.

Authors:  Ghassan K Abou-Alfa; Philip Johnson; Jennifer J Knox; Marinela Capanu; Irina Davidenko; Juan Lacava; Thomas Leung; Bolorsukh Gansukh; Leonard B Saltz
Journal:  JAMA       Date:  2010-11-17       Impact factor: 56.272

Review 4.  Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities.

Authors:  Pimprapa Vejpongsa; Edward T H Yeh
Journal:  J Am Coll Cardiol       Date:  2014-09-02       Impact factor: 24.094

  4 in total
  11 in total

1.  The Influence of Matrix-Induced Dormancy on Metastatic Breast Cancer Chemoresistance.

Authors:  Cindy J Farino; Shantanu Pradhan; John H Slater
Journal:  ACS Appl Bio Mater       Date:  2020-08-06

2.  Bioinspired particle engineering for non-invasive inhaled drug delivery to the lungs.

Authors:  Snehal K Shukla; Apoorva Sarode; Dipti D Kanabar; Aaron Muth; Nitesh K Kunda; Samir Mitragotri; Vivek Gupta
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2021-07-15

3.  One-Pot, One-Step Synthesis of Drug-Loaded Magnetic Multimicelle Aggregates.

Authors:  Chang Soo Kim; Dmitry Nevozhay; Rebeca Romero Aburto; Ashok Pehere; Lan Pang; Rebecca Dillard; Ziqiu Wang; Clayton Smith; Kelsey Boitnott Mathieu; Marie Zhang; John D Hazle; Robert C Bast; Konstantin Sokolov
Journal:  Bioconjug Chem       Date:  2022-05-06       Impact factor: 6.069

4.  Optoacoustic properties of Doxorubicin - A pilot study.

Authors:  Melanie A Kimm; Claudia Gross; Xose Luis Déan-Ben; Avihai Ron; Ernst J Rummeny; Hsiao-Chun Amy Lin; Carsten Höltke; Daniel Razansky; Moritz Wildgruber
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

5.  Aqueous Processed Biopolymer Interfaces for Single-Cell Microarrays.

Authors:  Vittorio Ferrara; Giovanni Zito; Giuseppe Arrabito; Sebastiano Cataldo; Michelangelo Scopelliti; Carla Giordano; Valeria Vetri; Bruno Pignataro
Journal:  ACS Biomater Sci Eng       Date:  2020-04-17

6.  Omics Analysis of Chemoresistant Triple Negative Breast Cancer Cells Reveals Novel Metabolic Vulnerabilities.

Authors:  Dimitris Kordias; Christina E Kostara; Styliani Papadaki; John Verigos; Eleni Bairaktari; Angeliki Magklara
Journal:  Cells       Date:  2022-08-31       Impact factor: 7.666

7.  Simple Detection of Unstained Live Senescent Cells with Imaging Flow Cytometry.

Authors:  Marco Malavolta; Robertina Giacconi; Francesco Piacenza; Sergio Strizzi; Maurizio Cardelli; Giorgia Bigossi; Serena Marcozzi; Luca Tiano; Fabio Marcheggiani; Giulia Matacchione; Angelica Giuliani; Fabiola Olivieri; Ilaria Crivellari; Antonio Paolo Beltrami; Alessandro Serra; Marco Demaria; Mauro Provinciali
Journal:  Cells       Date:  2022-08-12       Impact factor: 7.666

8.  Cooling-mediated protection from chemotherapy drug-induced cytotoxicity in human keratinocytes by inhibition of cellular drug uptake.

Authors:  Christopher Dunnill; Khalidah Ibraheem; Michael Peake; Myria Ioannou; Megan Palmer; Adrian Smith; Andrew Collett; Nikolaos T Georgopoulos
Journal:  PLoS One       Date:  2020-10-15       Impact factor: 3.240

9.  Optimised Electroporation for Loading of Extracellular Vesicles with Doxorubicin.

Authors:  Angus J Lennaárd; Doste R Mamand; Rim Jawad Wiklander; Samir El Andaloussi; Oscar P B Wiklander
Journal:  Pharmaceutics       Date:  2021-12-24       Impact factor: 6.321

10.  Fluorescent Silica Nanoparticles Targeting Mitochondria: Trafficking in Myeloid Cells and Application as Doxorubicin Delivery System in Breast Cancer Cells.

Authors:  Federica Sola; Mariele Montanari; Mara Fiorani; Chiara Barattini; Caterina Ciacci; Sabrina Burattini; Daniele Lopez; Alfredo Ventola; Loris Zamai; Claudio Ortolani; Stefano Papa; Barbara Canonico
Journal:  Int J Mol Sci       Date:  2022-03-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.